Lumiracoxib, also known as CGS 35189 and COX 189, is a COX-2 selective inhibitor non-steroidal anti-inflammatory drug, manufactured by Novartis and still sold in few countries, including Mexico, Ecuador and the Dominican Republic, under the trade name Prexige. Since its original approval, lumiracoxib has been withdrawn from the market in several countries, mostly due to its potential for causing liver failure (sometimes requiring liver transplantation). It has never been approved for use in the United States.
罗美昔布
luó měi xī bù
更新时间:2024-04-30 22:51:03
- 常用名罗美昔布英文名lumiracoxib
- CAS号220991-20-8分子量293.721
- 密度1.4±0.1 g/cm3沸点395.7±42.0 °C at 760 mmHg
- 分子式C15H13ClFNO2熔点139-141ºC
- MSDS闪点193.1±27.9 °C
- 符号信号词
罗美昔布 用途